{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:34:45Z","timestamp":1777430085673,"version":"3.51.4"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Coccidioidomycosis poses a significant cost and morbidity burden in the United States. Additionally, coccidioidomycosis requires constant decision-making related to prevention, diagnosis, and management. Delays in diagnosis lead to significant consequences, including unnecessary diagnostic workup and antibacterial therapy. Antifungal stewardship considerations regarding empiric, prophylactic, and targeted management of coccidioidomycosis are also complex. In this review, the problems facing antimicrobial stewardship programs (ASPs) in the endemic region for coccidioidomycosis, consequences due to delayed or missed diagnoses of coccidioidomycosis on antibacterial prescribing, and excess antifungal prescribing for prevention and treatment of coccidioidomycosis are elucidated. Finally, our recommendations and research priorities for ASPs in the endemic region for coccidioidomycosis are outlined.<\/jats:p>","DOI":"10.1093\/ofid\/ofae041","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T01:20:01Z","timestamp":1706145601000},"source":"Crossref","is-referenced-by-count":4,"title":["Challenges Facing Antimicrobial Stewardship Programs in the Endemic Region for Coccidioidomycosis"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4360-961X","authenticated-orcid":false,"given":"Justin F","family":"Hayes","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, University of Arizona , Tucson, Arizona , USA"},{"name":"Valley Fever Center for Excellence, University of Arizona , Tucson, Arizona , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9440-465X","authenticated-orcid":false,"given":"David E","family":"Nix","sequence":"additional","affiliation":[{"name":"Valley Fever Center for Excellence, University of Arizona , Tucson, Arizona , USA"},{"name":"Department of Pharmacy Practice and Science, University of Arizona , Tucson, Arizona , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"2024061711531450100_ofae041-B1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"2024061711531450100_ofae041-B2","author":"Centers for Disease Control and Prevention"},{"key":"2024061711531450100_ofae041-B3","first-page":"1","article-title":"APPROVED: new antimicrobial stewardship standard","volume":"36","author":"Joint Commission on Hospital Accreditation","year":"2016","journal-title":"Jt Comm Perspect"},{"key":"2024061711531450100_ofae041-B4","author":"Federal Register"},{"key":"2024061711531450100_ofae041-B5","doi-asserted-by":"crossref","first-page":"e180243","DOI":"10.1001\/jamanetworkopen.2018.0243","article-title":"Outpatient antibiotic prescribing for acute respiratory infections during influenza seasons","volume":"1","author":"Havers","year":"2018","journal-title":"JAMA Netw Open"},{"key":"2024061711531450100_ofae041-B6","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010\u20132011","volume":"315","author":"Fleming-Dutra","year":"2016","journal-title":"JAMA"},{"key":"2024061711531450100_ofae041-B7","doi-asserted-by":"crossref","first-page":"e045605","DOI":"10.1136\/bmjopen-2020-045605","article-title":"Incidence, duration and risk factors associated with delayed and missed diagnostic opportunities related to tuberculosis: a population-based longitudinal study","volume":"11","author":"Miller","year":"2021","journal-title":"BMJ Open"},{"key":"2024061711531450100_ofae041-B8","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2024061711531450100_ofae041-B9","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3201\/eid1206.060028","article-title":"Coccidioidomycosis as a common cause of community-acquired pneumonia","volume":"12","author":"Valdivia","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"2024061711531450100_ofae041-B10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3201\/eid1563.081007","article-title":"Coccidioidal pneumonia, Phoenix, Arizona, USA, 2000\u20132004","volume":"15","author":"Kim","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"2024061711531450100_ofae041-B11","doi-asserted-by":"crossref","first-page":"ofac654","DOI":"10.1093\/ofid\/ofac654","article-title":"Improving early recognition of coccidioidomycosis in urgent care clinics: analysis of an implemented education program","volume":"10","author":"Pu","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2024061711531450100_ofae041-B12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad619","article-title":"Clinical testing guidance for coccidioidomycosis, histoplasmosis, and blastomycosis in patients with community-acquired pneumonia for primary and urgent care providers [manuscript published online ahead of print 6 October 2023]","author":"Smith","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2024061711531450100_ofae041-B13","doi-asserted-by":"crossref","first-page":"e0158122","DOI":"10.1128\/jcm.01581-22","article-title":"Review of clinical and laboratory diagnostics for coccidioidomycosis","volume":"61","author":"McHardy","year":"2023","journal-title":"J Clin Microbiol"},{"key":"2024061711531450100_ofae041-B14","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024061711531450100_ofae041-B15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3201\/eid1407.070832","article-title":"Testing for coccidioidomycosis among patients with community-acquired pneumonia","volume":"14","author":"Chang","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"2024061711531450100_ofae041-B16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/mmy\/myx112","article-title":"Testing for coccidioidomycosis in emergency departments in Arizona","volume":"56","author":"Khan","year":"2018","journal-title":"Med Mycol"},{"key":"2024061711531450100_ofae041-B17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3201\/eid2404.161568","article-title":"Testing for coccidioidomycosis among community-acquired pneumonia patients, Southern California, USA","volume":"24","author":"Tartof","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2024061711531450100_ofae041-B18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/13693786.2010.547995","article-title":"Coccidioidomycosis: knowledge, attitudes, and practices among healthcare providers\u2014Arizona, 2007","volume":"49","author":"Chen","year":"2011","journal-title":"Med Mycol"},{"key":"2024061711531450100_ofae041-B19","doi-asserted-by":"crossref","first-page":"ofab020","DOI":"10.1093\/ofid\/ofab020","article-title":"Health care providers\u2019 testing practices for coccidioidomycosis and histoplasmosis in patients with community-acquired pneumonia\u2014United States, 2020","volume":"8","author":"Benedict","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2024061711531450100_ofae041-B20","doi-asserted-by":"crossref","first-page":"myad107","DOI":"10.1093\/mmy\/myad107","article-title":"Diagnostic delays in cutaneous coccidioidomycosis: a report from Central California","volume":"61","author":"Policepatil","year":"2023","journal-title":"Med Mycol"},{"key":"2024061711531450100_ofae041-B21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/jof9050554","article-title":"Genetic and other determinants for the severity of coccidioidomycosis: a clinician's perspective","volume":"9","author":"Galgiani","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"2024061711531450100_ofae041-B22","doi-asserted-by":"crossref","first-page":"e159491","DOI":"10.1172\/jci.insight.159491","article-title":"Immunogenetics associated with severe coccidioidomycosis","volume":"7","author":"Hsu","year":"2022","journal-title":"JCI Insight"},{"key":"2024061711531450100_ofae041-B23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11046-006-0062-5","article-title":"Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts","volume":"162","author":"Blair","year":"2006","journal-title":"Mycopathologia"},{"key":"2024061711531450100_ofae041-B24","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/ajt.12144","article-title":"The utility of diagnostic testing for active coccidioidomycosis in solid organ transplant recipients","volume":"13","author":"Mendoza","year":"2013","journal-title":"Am J Transplant"},{"key":"2024061711531450100_ofae041-B25","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3201\/eid2509.190023","article-title":"Delays in coccidioidomycosis diagnosis and associated healthcare utilization, Tucson, Arizona, USA","volume":"25","author":"Donovan","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2024061711531450100_ofae041-B26","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3201\/eid2508.190019","article-title":"Delays in coccidioidomycosis diagnosis and relationship to healthcare utilization, Phoenix, Arizona, USA","volume":"25","author":"Ginn","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2024061711531450100_ofae041-B27","doi-asserted-by":"crossref","first-page":"e1587","DOI":"10.1093\/cid\/ciaa739","article-title":"Clinician practice patterns that result in the diagnosis of coccidioidomycosis before or during hospitalization","volume":"73","author":"Pu","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024061711531450100_ofae041-B28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/mmy\/myz073","article-title":"Antibiotic and antifungal treatment among persons with confirmed coccidioidomycosis\u2014Southern California, 2011","volume":"58","author":"Chi","year":"2020","journal-title":"Med Mycol"},{"key":"2024061711531450100_ofae041-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7107a1","article-title":"Endemic Mycoses State Partners Group","volume":"71","author":"Smith","year":"2022","journal-title":"MMWR Surveill Summ"},{"key":"2024061711531450100_ofae041-B30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/infdis\/173.5.1273","article-title":"Detection of coccidioidal antibodies by 33-kDa spherule antigen, coccidioides EIA, and standard serologic tests in sera from patients evaluated for coccidioidomycosis","volume":"173","author":"Wieden","year":"1996","journal-title":"J Infect Dis"},{"key":"2024061711531450100_ofae041-B31","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1093\/mmy\/myy095","article-title":"Update on the epidemiology of coccidioidomycosis in the United States","volume":"57","author":"McCotter","year":"2019","journal-title":"Med Mycol"},{"key":"2024061711531450100_ofae041-B32","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1017\/ash.2021.201","article-title":"Outpatient antifungal prescribing patterns in the United States, 2018","volume":"1","author":"Benedict","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2024061711531450100_ofae041-B33","doi-asserted-by":"crossref","first-page":"ofad345","DOI":"10.1093\/ofid\/ofad345","article-title":"Trends of azole antifungal prescription in the United States: Medicare Part D provider utilization and payment data analysis","volume":"10","author":"Al-Obaidi","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2024061711531450100_ofae041-B34","doi-asserted-by":"crossref","first-page":"S417","DOI":"10.1093\/ofid\/ofaa439.928","article-title":"A descriptive analysis of fluconazole utilization at two academic medical centers in the Valley fever corridor of Arizona","volume":"7","author":"Hayes","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2024061711531450100_ofae041-B35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/clind\/16.3.349","article-title":"Coccidioidomycosis: new aspects of epidemiology and therapy","volume":"16","author":"Einstein","year":"1993","journal-title":"Clin Infect Dis"},{"key":"2024061711531450100_ofae041-B36","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/cid\/ciz933","article-title":"Treatment for early, uncomplicated coccidioidomycosis: what is success?","volume":"70","author":"Galgiani","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024061711531450100_ofae041-B37","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1093\/mmy\/myy029","article-title":"Current concepts and future directions in the pharmacology and treatment of coccidioidomycosis","volume":"57","author":"Thompson","year":"2019","journal-title":"Med Mycol"},{"key":"2024061711531450100_ofae041-B38","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/mmy\/myy019","article-title":"Coccidioidomycosis in selected immunosuppressed hosts","volume":"57","author":"Blair","year":"2019","journal-title":"Med Mycol"},{"key":"2024061711531450100_ofae041-B39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-6143.2005.01169.x","article-title":"Coccidioidomycosis after renal transplantation in an endemic area","volume":"6","author":"Braddy","year":"2006","journal-title":"Am J Transplant"},{"key":"2024061711531450100_ofae041-B40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-6143.2010.03328.x","article-title":"Coccidioidomycosis in liver transplant recipients in an endemic area","volume":"11","author":"Vucicevic","year":"2011","journal-title":"Am J Transplant"},{"key":"2024061711531450100_ofae041-B41","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12744","article-title":"Single-center experience of antifungal prophylaxis for coccidioidomycosis in heart transplant recipients within an endemic area","volume":"19","author":"Lohrmann","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"2024061711531450100_ofae041-B42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1034\/j.1399-3062.2003.00005.x","article-title":"Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area","volume":"5","author":"Blair","year":"2003","journal-title":"Transpl Infect Dis"},{"key":"2024061711531450100_ofae041-B43","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1111\/ajt.15324","article-title":"De novo coccidioidomycosis among solid organ transplant recipients 1 or more years after transplant","volume":"19","author":"Asbury","year":"2019","journal-title":"Am J Transplant"},{"key":"2024061711531450100_ofae041-B44","doi-asserted-by":"crossref","first-page":"e13553","DOI":"10.1111\/ctr.13553","article-title":"Endemic fungal infections in solid organ transplant recipients\u2014guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Miller","year":"2019","journal-title":"Clin Transplant"},{"key":"2024061711531450100_ofae041-B45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/ijd.14238","article-title":"Cutaneous effects associated with fluconazole in patients treated for coccidioidomycosis","volume":"58","author":"Brewer","year":"2019","journal-title":"Int J Dermatol"},{"key":"2024061711531450100_ofae041-B46","doi-asserted-by":"crossref","first-page":"e01384-18","DOI":"10.1128\/AAC.01384-18","article-title":"Examination of fluconazole-induced alopecia in an animal model and human cohort","volume":"63","author":"Thompson","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2024061711531450100_ofae041-B47","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jac\/dky501","article-title":"Tolerability of long-term fluconazole therapy","volume":"74","author":"Davis","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2024061711531450100_ofae041-B48","doi-asserted-by":"crossref","first-page":"170S","DOI":"10.1002\/j.1875-9114.1990.tb02605.x","article-title":"Drug interactions with fluconazole","volume":"10","author":"Kowalsky","year":"1990","journal-title":"Pharmacotherapy"},{"key":"2024061711531450100_ofae041-B49","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1093\/clinids\/12.Supplement_3.S327","article-title":"Drug interactions with fluconazole","volume":"12","author":"Lazar","year":"1990","journal-title":"Rev Infect Dis"},{"key":"2024061711531450100_ofae041-B50","first-page":"1244","article-title":"Fluconazole-induced long QT syndrome via impaired human ether-a-go-go-related gene (hERG) protein trafficking in rabbits","volume":"19","author":"Wang","year":"2017","journal-title":"Europace"},{"key":"2024061711531450100_ofae041-B51","first-page":"105","article-title":"Torsade de pointes during sevoflurane anesthesia and fluconazole infusion in a patient with long QT syndrome. A case report","volume":"62","author":"Tacken","year":"2011","journal-title":"Acta Anaesthesiol Belg"},{"key":"2024061711531450100_ofae041-B52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/13693780500088416","article-title":"In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi","volume":"43","author":"Gonz\u00e1lez","year":"2005","journal-title":"Med Mycol"},{"key":"2024061711531450100_ofae041-B53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11046-005-0177-0","article-title":"In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from northeast, Brazil","volume":"161","author":"Cordeiro","year":"2006","journal-title":"Mycopathologia"},{"key":"2024061711531450100_ofae041-B54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11046-007-9018-7","article-title":"Antifungal susceptibility profiles of Coccidioides immitis and Coccidioides posadasii from endemic and non-endemic areas","volume":"163","author":"Ramani","year":"2007","journal-title":"Mycopathologia"},{"key":"2024061711531450100_ofae041-B55","doi-asserted-by":"crossref","first-page":"e02634-16","DOI":"10.1128\/AAC.02634-16","article-title":"Large-scale evaluation of in vitro amphotericin B, triazole, and echinocandin activity against Coccidioides species from U.S. institutions","volume":"61","author":"Thompson","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2024061711531450100_ofae041-B56","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/cid\/ciad146","article-title":"Isavuconazole in the treatment of chronic forms of coccidioidomycosis","volume":"76","author":"Heidari","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2024061711531450100_ofae041-B57","doi-asserted-by":"crossref","first-page":"e02232-18","DOI":"10.1128\/AAC.02232-18","article-title":"Isavuconazole in the treatment of coccidioidal meningitis","volume":"63","author":"Heidari","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2024061711531450100_ofae041-B58","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/cid\/cir642","article-title":"Treatment of refractory coccidioidomycosis with voriconazole or posaconazole","volume":"53","author":"Kim","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2024061711531450100_ofae041-B59","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1196\/annals.1406.019","article-title":"Amphotericin B and coccidioidomycosis","volume":"1111","author":"Johnson","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"2024061711531450100_ofae041-B60","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1017\/ash.2023.160","article-title":"The perfect storm: respiratory viral surges and anti-infective shortages","volume":"3","author":"Gross","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2024061711531450100_ofae041-B61","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1017\/ice.2021.426","article-title":"Antifungal drug shortage in India amid an increase in invasive fungal functions during the coronavirus disease 2019 (COVID-19) pandemic","volume":"43","author":"Arun","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2024061711531450100_ofae041-B62","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1210\/js.2019-00189","article-title":"Posaconazole-induced hypertension due to inhibition of 11\u03b2-hydroxylase and 11\u03b2-hydroxysteroid dehydrogenase 2","volume":"3","author":"Thompson","year":"2019","journal-title":"J Endocr Soc"},{"key":"2024061711531450100_ofae041-B63","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/ctr.12834","article-title":"Adverse effects of voriconazole: over a decade of use","volume":"30","author":"Levine","year":"2016","journal-title":"Clin Transplant"},{"key":"2024061711531450100_ofae041-B64","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1093\/infdis\/jiaa394","article-title":"Core recommendations for antifungal stewardship: a statement of the Mycoses Study Group Education and Research Consortium","volume":"222","author":"Johnson","year":"2020","journal-title":"J Infect Dis"},{"key":"2024061711531450100_ofae041-B65","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ajt.16743","article-title":"White paper on antimicrobial stewardship in solid organ transplant recipients","volume":"22","author":"So","year":"2022","journal-title":"Am J Transplant"},{"key":"2024061711531450100_ofae041-B66","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/myc.12838","article-title":"Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German Society for Hematology and Medical Oncology (AGIHO)","volume":"61","author":"Ruhnke","year":"2018","journal-title":"Mycoses"},{"key":"2024061711531450100_ofae041-B67","doi-asserted-by":"crossref","first-page":"ofac234","DOI":"10.1093\/ofid\/ofac234","article-title":"The role of diagnostics-driven antifungal stewardship in the management of invasive fungal infections: a systematic literature review","volume":"9","author":"Chakrabarti","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2024061711531450100_ofae041-B68","author":"Centers for Disease Control and Prevention"},{"key":"2024061711531450100_ofae041-B69","author":"The Joint Commission"},{"key":"2024061711531450100_ofae041-B70","first-page":"700","article-title":"Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis","volume":"12","author":"Ampel","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"2024061711531450100_ofae041-B71","doi-asserted-by":"crossref","first-page":"e00065-18","DOI":"10.1128\/mSphere.00065-18","article-title":"Ex vivo cytokine release, determined by a multiplex cytokine assay, in response to coccidioidal antigen stimulation of whole blood among subjects with recently diagnosed primary pulmonary coccidioidomycosis","volume":"3","author":"Ampel","year":"2018","journal-title":"mSphere"},{"key":"2024061711531450100_ofae041-B72","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1016\/j.vaccine.2021.10.029","article-title":"\u0394cps1 vaccine protects dogs against experimentally induced coccidioidomycosis","volume":"39","author":"Shubitz","year":"2021","journal-title":"Vaccine"},{"key":"2024061711531450100_ofae041-B73","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1017\/ice.2023.156","article-title":"Improving antimicrobial use through better diagnosis: the relationship between diagnostic stewardship and antimicrobial stewardship","volume":"44","author":"Ku","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2024061711531450100_ofae041-B74","doi-asserted-by":"crossref","first-page":"ofad412","DOI":"10.1093\/ofid\/ofad412","article-title":"Improving the efficiency of antimicrobial stewardship action in acute care facilities","volume":"10","author":"Heil","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2024061711531450100_ofae041-B75","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-051806","article-title":"A multisite collaborative to decrease inappropriate antibiotics in urgent care centers","volume":"150","author":"Nedved","year":"2022","journal-title":"Pediatrics"},{"key":"2024061711531450100_ofae041-B76","doi-asserted-by":"crossref","first-page":"e2313011","DOI":"10.1001\/jamanetworkopen.2023.13011","article-title":"Implementation of an antibiotic stewardship initiative in a large urgent care network","volume":"6","author":"Stenehjem","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2024061711531450100_ofae041-B77","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/cid\/ciz910","article-title":"Antibiotic prescribing variability in a large urgent care network: a new target for outpatient stewardship","volume":"70","author":"Stenehjem","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024061711531450100_ofae041-B78","author":"UArizona Health Sciences"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae041\/56408112\/ofae041.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/6\/ofae041\/58234253\/ofae041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/6\/ofae041\/58234253\/ofae041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T11:54:21Z","timestamp":1718625261000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae041\/7588613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae041","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,1,24]]},"article-number":"ofae041"}}